Drug-resistant bacteria found in eye drops has infected 55 people in 12 states
February 3, 2023Medical Communications
A strongly drug-resistant bacteria has been found in multiple brands of artificial tears eyedrops; the most commonly reported was EzriCare …
DrugBAN AI expected to reduce costs and speed up drug discovery
February 3, 2023Medical Communications
In a collaboration between Sheffield University and pharma giant, AstraZeneca, a new AI has been developed which could help deliver …
Genoscience Pharma received Orphan Drug Designation for hepatocellular carcinoma drug
February 3, 2023Medical Communications
French clinical-stage biotech company Genoscience has received FDA Orphan Drug Designation (ODD) for its lead candidate ezurpimtrostat. OOD qualifies the …
Insilico Medicine opens new R&D facility in Abu Dhabi
February 3, 2023Research and Development
Hong Kong-based healthtech company Insilico Medicine recently opened its eighth global laboratory in Abu Dhabi. Utilising Abu Dhabi’s Masdar …
Novartis announces cut to multiple drug research programmes in 2022 full-year report
February 2, 2023Business Services
Novartis, a Swiss pharmaceutical company, has announced in its 2022 full-year report that it is cutting several of their programmes, …
Sherlock Biosciences acquires Sense Biodetection to advance CRISPR-based diagnostics
February 2, 2023Business Services
US-based biotech company Sherlock Biosciences has acquired UK-based developer of rapid molecular diagnostics Sense Biodetection. The acquisition will integrate …
Tadashi Maruno
February 2, 2023Sales and Marketing
Hamamatsu Photonics Announces Mr. Tadashi Maruno as Representative Director and PresidentHamamatsu Photonics, a leading provider of cutting-edge photonics technology, …
Joydeep Goswami
February 2, 2023Sales and Marketing
Illumina Appoints Joydeep Goswami Chief Financial Officer
PureTech to Present at the SVB Securities Global Biopharma Conference
February 1, 2023Business Services
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment …
Ellipses Pharma announces FDA approval of IND application for EP0042 for patients with acute myeloid leukaemia
February 1, 2023Business Services
Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an …
ViCentra bolsters leadership team with the appointment of Leo Toole as Chief Financial Officer and expands European commercialization
February 1, 2023Business Services
February 1, Utrecht, The Netherlands ViCentra B.V., the company behind Kaleido, one of the world’s smallest, lightest and most …
Germo Gericke, MD
February 1, 2023Business Services
Dr. Gericke brings extensive experience in the research and development of radioligand therapies Appointment coincides with launch of Ariceum International …
Sequana Medical announces grant of additional DSR® patent in United States
February 1, 2023Business Services
Ghent, Belgium – 1 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medic
Neuraxpharm announces closing of acquisition of established products from Sanofi
February 1, 2023Business Services
Düsseldorf and Barcelona – February 1, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the …
Dr Jean-Michel Cosséry
February 1, 2023Business Services
Jean-Michel brings 25 years of experience in the international pharmaceutical and biotech industries both in an executive and non-executive capacity …
COVID-19 treatments drive Pfizer’s annual earnings up to $100bn
February 1, 2023Sales and Marketing
Big Pharma giant Pfizer’s annual earnings in 2022 reached $100bn, a considerable proportion of which came from its COVID-19 vaccine …
Adding veliparib to chemotherapy can extend progression-free survival in in some breast cancer patients
February 1, 2023Research and Development
It appears that adding veliparib to chemotherapy can extend progression-free survival (PFS) in patients suffering from triple negative breast cancer …
NaDeNo’s nanomedicine delivery system inspires hope for peritoneal cancer
February 1, 2023Research and Development
NaDeNo, a new nanomedicines company and spin-off of the Norwegian science institute SINTEF, has revealed promising results for its cure …
FDA approves Axonics’ neurostimulator
February 1, 2023Medical Communications
US-based medtech company Axonics have received FDA approval for their fourth-generation, rechargeable sacral neuromodulation system for the treatment of chronic …
Rare and Orphan disease expert Terebellum to launch incisive Specialty Pharmacy development bulletins, Specialty Pharmaceutical Pulse™
January 31, 2023Business Services
Global healthcare and business consulting services provider Terebellum is launching a brand-new monthly Specialty Pharmaceutical Pulse™ insights bulletin in the …
Latest content
FibroFind appoints Lee Borthwick as CEO
